Literature DB >> 3396409

Pulmonary function of nonsmoking patients with systemic lupus erythematosus.

A P Andonopoulos1, S H Constantopoulos, V Galanopoulou, A A Drosos, N C Acritidis, H M Moutsopoulos.   

Abstract

The pulmonary function of 70 nonsmoking patients with systemic lupus erythematosus (SLE) was evaluated, and the results were compared with those of 70 age- and sex-matched, nonsmoking healthy individuals. Isolated reduction of carbon monoxide diffusing lung capacity (DCO), usually subclinical, was the most commonly detected functional abnormality in the SLE population, whereas it was absent in the comparison group. Isolated small airways disease (SAD) was observed in a relatively high percentage of patients, but not significantly different from that in the healthy people. Restrictive and obstructive patterns were very unusual in the SLE people and absent in the members of the comparison group. Finally, normal lung function was seen in the majority of the latter, but only in one third of the lupus patients. Subclinical respiratory dysfunction, most commonly expressed as diminished DCO, is a common feature of SLE.

Entities:  

Mesh:

Year:  1988        PMID: 3396409     DOI: 10.1378/chest.94.2.312

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

2.  Characterization of lymphangioleiomyomatosis patients with discordance between spirometric and diffusion measurements of pulmonary function.

Authors:  Andrew M Courtwright; Bruno G Baldi; Pranav Kidambi; Ye Cui; Anthony M Lamattina; Julian A Villalba; Shefali Bagwe; Hilary J Goldberg; Ivan O Rosas; Elizabeth Petri Henske; Carlos R R Carvalho; Souheil El-Chemaly
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Extent of subclinical pulmonary involvement in childhood onset systemic lupus erythematosus in the sultanate of oman.

Authors:  Eiman Abdulla; Ibrahim Al-Zakwani; Sawsan Baddar; Reem Abdwani
Journal:  Oman Med J       Date:  2012-01

4.  Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE).

Authors:  H Groen; M Aslander; H Bootsma; T W van der Mark; C G Kallenberg; D S Postma
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

5.  Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.

Authors:  B Godeau; C Cormier; C J Menkes
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

6.  Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens.

Authors:  S A Evans; N D Hopkinson; W J Kinnear; L Watson; R J Powell; I D Johnston
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

7.  Gas transfer and pulmonary function tests in women with disseminated lupus erythematosus.

Authors:  Babak Amra; Bijan Iraj; Zahra Seyyed Benakdar; Hamid Sanei; Golshan Mohammad
Journal:  ARYA Atheroscler       Date:  2012

8.  Diffuse Alveolar Hemorrhage without Extrapulmonary Manifestations: A Rare Presentation of Lupus.

Authors:  Bharat Bajantri; Binita Sapkota; Sindhaghatta Venkatram
Journal:  Am J Case Rep       Date:  2018-02-28

Review 9.  Respiratory Manifestations in Systemic Lupus Erythematosus.

Authors:  Salvatore Di Bartolomeo; Alessia Alunno; Francesco Carubbi
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.